Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 57

1.

The Urinary Transcriptome as a Source of Biomarkers for Prostate Cancer.

Solé C, Goicoechea I, Goñi A, Schramm M, Armesto M, Arestin M, Manterola L, Tellaetxe M, Alberdi A, Nogueira L, Roumiguie M, López JI, Sanz Jaka JP, Urruticoechea A, Vergara I, Loizaga-Iriarte A, Unda M, Carracedo A, Malavaud B, Lawrie CH.

Cancers (Basel). 2020 Feb 22;12(2). pii: E513. doi: 10.3390/cancers12020513.

2.

Sequential treatment of metastatic renal cancer in a complex evolving landscape.

Angulo JC, Lawrie CH, López JI.

Ann Transl Med. 2019 Dec;7(Suppl 8):S272. doi: 10.21037/atm.2019.12.05. No abstract available.

3.

Serum levels of hsa-miR-16-5p, hsa-miR-29a-3p, hsa-miR-150-5p, hsa-miR-155-5p and hsa-miR-223-3p and subsequent risk of chronic lymphocytic leukemia in the EPIC study.

Casabonne D, Benavente Y, Seifert J, Costas L, Armesto M, Arestin M, Besson C, Hosnijeh FS, Duell EJ, Weiderpass E, Masala G, Kaaks R, Canzian F, Chirlaque MD, Perduca V, Mancini FR, Pala V, Trichopoulou A, Karakatsani A, La Vecchia C, Sánchez MJ, Tumino R, Gunter MJ, Amiano P, Panico S, Sacerdote C, Schmidt JA, Boeing H, Schulze MB, Barricarte A, Riboli E, Olsen A, Tjønneland A, Vermeulen R, Nieters A, Lawrie CH, de Sanjosé S.

Int J Cancer. 2020 Feb 3. doi: 10.1002/ijc.32894. [Epub ahead of print]

PMID:
32012253
4.

MicroRNAs and Metastasis.

Solé C, Lawrie CH.

Cancers (Basel). 2019 Dec 30;12(1). pii: E96. doi: 10.3390/cancers12010096. Review.

5.

Oncogenic Roles and Inhibitors of DNMT1, DNMT3A, and DNMT3B in Acute Myeloid Leukaemia.

Wong KK, Lawrie CH, Green TM.

Biomark Insights. 2019 May 8;14:1177271919846454. doi: 10.1177/1177271919846454. eCollection 2019. Review.

6.

The circulating transcriptome as a source of cancer liquid biopsy biomarkers.

Sole C, Arnaiz E, Manterola L, Otaegui D, Lawrie CH.

Semin Cancer Biol. 2019 Oct;58:100-108. doi: 10.1016/j.semcancer.2019.01.003. Epub 2019 Jan 23. Review.

PMID:
30684535
7.

The Circulating Transcriptome as a Source of Biomarkers for Melanoma.

Solé C, Tramonti D, Schramm M, Goicoechea I, Armesto M, Hernandez LI, Manterola L, Fernandez-Mercado M, Mujika K, Tuneu A, Jaka A, Tellaetxe M, Friedländer MR, Estivill X, Piazza P, Ortiz-Romero PL, Middleton MR, Lawrie CH.

Cancers (Basel). 2019 Jan 10;11(1). pii: E70. doi: 10.3390/cancers11010070.

8.

CircRNAs and cancer: Biomarkers and master regulators.

Arnaiz E, Sole C, Manterola L, Iparraguirre L, Otaegui D, Lawrie CH.

Semin Cancer Biol. 2019 Oct;58:90-99. doi: 10.1016/j.semcancer.2018.12.002. Epub 2018 Dec 11. Review.

PMID:
30550956
9.

MicroRNAs as Biomarkers of B-cell Lymphoma.

Solé C, Arnaiz E, Lawrie CH.

Biomark Insights. 2018 Oct 16;13:1177271918806840. doi: 10.1177/1177271918806840. eCollection 2018. Review.

10.

Potential impact of PD-L1 (SP-142) immunohistochemical heterogeneity in clear cell renal cell carcinoma immunotherapy.

López JI, Pulido R, Cortés JM, Angulo JC, Lawrie CH.

Pathol Res Pract. 2018 Aug;214(8):1110-1114. doi: 10.1016/j.prp.2018.06.003. Epub 2018 Jun 12.

PMID:
29910061
11.

Spatial intratumoural heterogeneity in the expression of GIT1 is associated with poor prognostic outcome in oestrogen receptor positive breast cancer patients with synchronous lymph node metastases.

Goicoechea I, Rezola R, Arestin M, M Caffarel M, Cortazar AR, Manterola L, Fernandez-Mercado M, Armesto M, Sole C, Larrea E, M Araujo A, Ancizar N, Plazaola A, Urruticoechea A, Carracedo A, Ruiz I, Alvarez Lopez I, H Lawrie C.

Version 2. F1000Res. 2017 Aug 30 [revised 2018 Jan 1];6:1606. doi: 10.12688/f1000research.12393.2. eCollection 2017.

12.

Loss of PD-L1 (SP-142) expression characterizes renal vein tumor thrombus microenvironment in clear cell renal cell carcinoma.

López JI, Pulido R, Lawrie CH, Angulo JC.

Ann Diagn Pathol. 2018 Jun;34:89-93. doi: 10.1016/j.anndiagpath.2018.03.007. Epub 2018 Mar 24.

PMID:
29661736
13.

High levels of intratumor heterogeneity characterize the expression of epithelial-mesenchymal transition markers in high-grade clear cell renal cell carcinoma.

Guarch R, Lawrie CH, Larrinaga G, Angulo JC, Pulido R, López JI.

Ann Diagn Pathol. 2018 Jun;34:27-30. doi: 10.1016/j.anndiagpath.2018.01.001. Epub 2018 Jan 10.

PMID:
29661723
14.

Dysregulation of Mir-196b in Head and Neck Cancers Leads to Pleiotropic Effects in the Tumor Cells and Surrounding Stromal Fibroblasts.

Álvarez-Teijeiro S, Menéndez ST, Villaronga MÁ, Rodrigo JP, Manterola L, de Villalaín L, de Vicente JC, Alonso-Durán L, Fernández MP, Lawrie CH, García-Pedrero JM.

Sci Rep. 2017 Dec 19;7(1):17785. doi: 10.1038/s41598-017-18138-8.

15.

DNMT1 is predictive of survival and associated with Ki-67 expression in R-CHOP-treated diffuse large B-cell lymphomas.

Loo SK, Ch'ng ES, Lawrie CH, Muruzabal MA, Gaafar A, Pomposo MP, Husin A, Md Salleh MS, Banham AH, Pedersen LM, Møller MB, Green TM, Wong KK.

Pathology. 2017 Dec;49(7):731-739. doi: 10.1016/j.pathol.2017.08.009. Epub 2017 Oct 23.

PMID:
29074044
16.

Noncoding RNA Expression and Targeted Next-Generation Sequencing Distinguish Tubulocystic Renal Cell Carcinoma (TC-RCC) from Other Renal Neoplasms.

Lawrie CH, Armesto M, Fernandez-Mercado M, Arestín M, Manterola L, Goicoechea I, Larrea E, Caffarel MM, Araujo AM, Sole C, Sperga M, Alvarado-Cabrero I, Michal M, Hes O, López JI.

J Mol Diagn. 2018 Jan;20(1):34-45. doi: 10.1016/j.jmoldx.2017.09.002. Epub 2017 Oct 19.

17.

Expression and activity of angiotensin-regulating enzymes is associated with prognostic outcome in clear cell renal cell carcinoma patients.

Errarte P, Beitia M, Perez I, Manterola L, Lawrie CH, Solano-Iturri JD, Calvete-Candenas J, Unda M, López JI, Larrinaga G.

PLoS One. 2017 Aug 15;12(8):e0181711. doi: 10.1371/journal.pone.0181711. eCollection 2017.

18.

Nanoparticle-Based Discrimination of Single-Nucleotide Polymorphism in Long DNA Sequences.

Sanromán-Iglesias M, Lawrie CH, Liz-Marzán LM, Grzelczak M.

Bioconjug Chem. 2017 Apr 19;28(4):903-906. doi: 10.1021/acs.bioconjchem.7b00028. Epub 2017 Mar 1.

PMID:
28225258
19.

SOX9 Elevation Acts with Canonical WNT Signaling to Drive Gastric Cancer Progression.

Santos JC, Carrasco-Garcia E, Garcia-Puga M, Aldaz P, Montes M, Fernandez-Reyes M, de Oliveira CC, Lawrie CH, Araúzo-Bravo MJ, Ribeiro ML, Matheu A.

Cancer Res. 2016 Nov 15;76(22):6735-6746. doi: 10.1158/0008-5472.CAN-16-1120. Epub 2016 Aug 28.

20.

Multi-site tumor sampling (MSTS) improves the performance of histological detection of intratumor heterogeneity in clear cell renal cell carcinoma (CCRCC).

Guarch R, Cortés JM, Lawrie CH, López JI.

Version 2. F1000Res. 2016 Aug 17 [revised 2016 Jan 1];5:2020. eCollection 2016.

Supplemental Content

Loading ...
Support Center